Live Breaking News & Updates on Inovio pharmaceuticals price performance

Stay informed with the latest breaking news from Inovio pharmaceuticals price performance on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Inovio pharmaceuticals price performance and stay connected to the pulse of your community

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Up 10.8% in March

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 2,060,000 shares, an increase of 10.8% from the February 29th total of 1,860,000 shares. Based on an average trading volume of 526,600 shares, the short-interest ratio […]

Canada , Metlife-investment-management , Inovio-pharmaceuticals , Charles-schwab-investment-management-inc , Nasdaq , Hsbc-holdings , Royal-bank , News-ratings-for-inovio-pharmaceuticals-daily , Vanguard-group-inc , Renaissance-technologies , Inovio-pharmaceuticals-inc

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" by StockNews.com

StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a research note published on Friday. A number of other research firms have also recently issued reports on INO. JMP Securities initiated coverage on Inovio Pharmaceuticals in a research note on Thursday, January 4th. They issued […]

Canada , Inovio-pharmaceuticals-inc , News-ratings-for-inovio-pharmaceuticals-daily , Inovio-pharmaceuticals-price-performance , Royal-bank , Principal-financial-group-inc , Allspring-global-investments-holdings , Inovio-pharmaceuticals , Free-report , Global-investments-holdings , Point-capital-management

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com

StockNews.com downgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a hold rating to a sell rating in a research note published on Friday morning. A number of other equities analysts have also recently commented on the company. JMP Securities started coverage on Inovio Pharmaceuticals in a report on Thursday, January 4th. They issued […]

Nasdaq , E-fund-management-co , Inovio-pharmaceuticals , Hsbc-holdings , Inovio-pharmaceuticals-price-performance , Nuveen-asset-management , Group-plc , News-ratings-for-inovio-pharmaceuticals-daily , Inovio-pharmaceuticals-inc , Fund-management-co , Hedge-funds-weigh-in-on-inovio-pharmaceuticals

Inovio Pharmaceuticals (NASDAQ:INO) Shares Down 6.8%

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report)’s share price was down 6.8% during mid-day trading on Thursday . The stock traded as low as $6.41 and last traded at $6.46. Approximately 126,013 shares changed hands during trading, a decline of 79% from the average daily volume of 599,254 shares. The stock had previously closed […]

Inovio-pharmaceuticals-price-performance , Inovio-pharmaceuticals-inc , Allspring-global-investments-holdings , Ci-private-wealth , Inovio-pharmaceuticals-company-profile , Nasdaq , Inovio-pharmaceuticals , News-ratings-for-inovio-pharmaceuticals-daily , Get-free-report , Global-investments-holdings , Point-capital-management

Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) in a research report issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance Shares of NASDAQ INO opened at $0.38 on Tuesday. The stock has a market capitalization of […]

Acadian-asset-management , Inovio-pharmaceuticals-inc , Allspring-global-investments-holdings , News-ratings-for-inovio-pharmaceuticals-daily , Inovio-pharmaceuticals , Cedar-brook-financial-partners , Hedge-funds-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals-price-performance , Keystone-financial-group , Pathstone-family-office , Get-free-report

Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance INO stock opened at $0.38 on Monday. The business has a 50 day simple moving average of $0.41 and a 200-day simple […]

Blackrock-inc , Inovio-pharmaceuticals-company-profile , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals-price-performance , Vanguard-group-inc , Inovio-pharmaceuticals-inc , Millennium-management , Renaissance-technologies , News-ratings-for-inovio-pharmaceuticals-daily , Inovio-pharmaceuticals , Free-report

Keystone Financial Group Buys Shares of 106,397 Inovio Pharmaceuticals, Inc. (NASDAQ:INO)

Keystone Financial Group acquired a new stake in shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) in the second quarter, HoldingsChannel.com reports. The fund acquired 106,397 shares of the biopharmaceutical company’s stock, valued at approximately $48,000. Other institutional investors and hedge funds also recently bought and sold shares of the company. Legal & General […]

Inovio-pharmaceuticals-profile , E-fund-management-co , Nuveen-asset-management , Inovio-pharmaceuticals , News-ratings-for-inovio-pharmaceuticals-daily , Quarter-for-inovio-pharmaceuticals , Hsbc-holdings , Inovio-pharmaceuticals-price-performance , Keystone-financial-group , Fund-management-co , Nasdaq

Inovio Pharmaceuticals (NASDAQ:INO) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance Shares of Inovio Pharmaceuticals stock opened at $0.40 on Monday. The business has a 50-day simple moving average […]

Inovio-pharmaceuticals-price-performance , Inovio-pharmaceuticals-inc , Hedge-funds-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals , Allspring-global-investments-holdings , News-ratings-for-inovio-pharmaceuticals-daily , Beck-bode , Capital-investment-advisors , Get-free-report , Global-investments-holdings , Exoduspoint-capital-management

Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research note published on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance INO opened at $0.58 on Friday. The company has a market capitalization of $151.21 million, a price-to-earnings ratio of -0.59 […]

News-ratings-for-inovio-pharmaceuticals-daily , Hedge-funds-weigh-in-on-inovio-pharmaceuticals , Blackrock-inc , Inovio-pharmaceuticals-inc , Renaissance-technologies , Inovio-pharmaceuticals , Inovio-pharmaceuticals-price-performance , Millennium-management , Vanguard-group-inc , Free-report , Get-free-report

Inovio Pharmaceuticals (NASDAQ:INO) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance NASDAQ INO opened at $0.53 on Friday. Inovio Pharmaceuticals has a one year low of $0.38 and a one year […]

Inovio-pharmaceuticals-inc , Vanguard-group-inc , Hsbc-holdings , Inovio-pharmaceuticals , Renaissance-technologies , Metlife-investment-management , Charles-schwab-investment-management-inc , News-ratings-for-inovio-pharmaceuticals-daily , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals-price-performance , Free-report